| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 13,378 | 8,554 | 13,501 | 15,364 | | Cost of Revenue | 4,086 | 4,346 | 2,641 | 3,035 | | | Gross Profit | 9,292 | 4,207 | 10,861 | 12,329 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 12,569 | 11,708 | 12,968 | 14,111 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,277) | (7,501) | (2,108) | (1,782) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 27 | (8,824) | (1,092) | 72 | | Earnings Before Interest And Taxes | (3,250) | (16,687) | (3,259) | (1,915) | | Interest Expense | 67 | 126 | 126 | 222 | | Income Before Tax | (3,317) | (16,812) | (3,385) | (2,137) | | Income Tax Expense | 146 | (482) | (444) | (435) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,463) | (16,330) | (2,941) | (1,702) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,463) | (16,330) | (2,941) | (1,702) | | Preferred Stock And Other Adjustments | (192) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,655) | ($16,330) | ($2,941) | ($1,702) |
|
0.20% Nasdaq 
Income Statement
